ISPOR RECOGNIZES FIVE DISTINGUISHED RECIPIENTS OF 2016 SERVICE AWARDS AT 19TH ANNUAL EUROPEAN CONGRESS

Published Nov 2, 2016
Awards Recognize Excellence in HEOR  Vienna, Austria—2 November 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) recognized recipients at its 19th Annual European Congress in Vienna, Austria. The ISPOR Awards Program is designed to foster and recognize excellence and outstanding technical achievement in health economics and outcomes research (HEOR). The 2016 ISPOR Awards Program recipients honored at the European Congress include: 1 November 2016
  • Jaime Caro,  MDCM, FRCPC Chief Scientist at Evidera 
ISPOR Marilyn Dix Smith Leadership Award For his trailblazing experience and his years of leadership and service to the Society, J. Jaimie Caro, MDMCM, FRCP, has been selected to receive ISPOR’s 2016 Marilyn Dix Smith Leadership Award. Dr. Caro has long been recognized as a pioneer in developing novel techniques and methodologies that advance the science of health economics and outcomes research. Together, Dr. Caro’s body of work in the field and his service to ISPOR epitomize the Society’s mission to promote health economics and outcomes research excellence to improve decision making for health globally. The ISPOR Marilyn Dix Smith Leadership Award is international in scope and stature and recognizes one individual each year that has provided extraordinary leadership to the Society.  The 2016 Marilyn Dix Smith Leadership Award was presented to Dr. Caro by Scott D. Ramsey, MD, PhD, Chair, ISPOR Marilyn Dix Smith Leadership Award Committee and Co-Director, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. 1 November 2016
  • Hans-Georg Eichler, MD, MSc Senior Medical Officer, European Medicines Agency (EMA), London, United Kingdom
  • Tomasz Hermanowski, PhD InterQuality Project Leader and Professor and Head, Department of Pharmacoeconomics, Medical University of Warsaw, Warsaw, Poland
For their dedicated service as Co-Chairs of ISPOR’s 19th Annual European Congress, Drs. Eichler and Hermanowski were recognized for their efforts in developing the scientific program for the 2016 meeting and for their continued service to ISPOR over the course of the years. 2 November 2016
  • Mirjana Huić, MD, PhD Assistant Director, Department for Development, Research, and Health, Technology Assessment, Agency for Quality and Accreditation in Health Care and Social Welfare (AAZ), Zagreb, Croatia
  • Alric Rüther, MD, PhD Head, International Affairs, Institute for Quality and Efficiency in Health Care, Cologne, Germany
For their dedicated service as Co-Chairs of ISPOR’s Health Technology Assessment (HTA) Roundtable Europe, Drs. Huić and Rüther were recognized for their efforts and for their continued service to ISPOR.  The ISPOR Distinguished Service Awards for the 19th Annual European Congress were presented by Lou Garrison, PhD, ISPOR 2016-2017 President and Professor, Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle, WA, USA. Additional information on the ISPOR 19th Annual European Congress can be found here. Released presentations from the congress can be found here. Interested parties can follow news and developments from the conference on social media using the hashtag #ISPORVienna.

###

   

Related Stories

New Research Collection Reveals How Artificial Intelligence Is Reshaping Health Economics

Nov 6, 2025

The PhRMA Foundation and ISPOR announced the publication of a special themed section of research papers that explores the dynamic intersection of artificial intelligence (AI) and health economics and outcomes research (HEOR).

ISPOR Announces 2025 Health Economics and Outcomes Research Award Honorees

Oct 20, 2025

ISPOR announced the recipients of its 2025 Health Economics and Outcomes Research (HEOR) Scientific and Leadership Awards. ISPOR Scientific Awards are designed to foster and recognize excellence and outstanding achievement in HEOR and its Leadership Awards recognize excellence and outstanding leadership in the field.

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×